{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:11:23Z","timestamp":1772133083058,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Geriatr Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>With aging population and the growing burden of sarcopenia on health systems, early risk assessment is essential. This study assessed the risk of sarcopenia and associated factors among community-dwelling older adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study used data from the Israel National Elderly Falls Survey (2018\u20132019) among adults aged 65+ by the Israel Center for Disease Control. Data were collected via telephone interviews on demographic, health, and functional characteristics. Sarcopenia risk was assessed using the validated five-item Mini Sarcopenia Risk Assessment (MSRA-5) questionnaire, with a cutoff score of\u2009\u2264\u200945 indicating risk. Multivariable logistic regression estimated odds ratios (ORs) and 95% confidence intervals (CIs) for sarcopenia risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 2668 participants were included in the study, with a mean age of 73.2\u2009\u00b1\u20095.7 years, and 56.3% were female. Based on the MSRA-5 cutoff score (\u2264\u200945), 65.1% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091738) were classified as at risk for sarcopenia. Older age (OR\u2009=\u20091.21 per 5-year increase, 95% CI 1.10\u20131.33), Arab ethnicity (OR\u2009=\u20092.05, 95% CI 1.59\u20132.64), lower education level (OR\u2009=\u20091.57, 95% CI 1.29\u20131.92), and anxiety\/depression (OR\u2009=\u20091.83, 95% CI 1.32\u20132.54) were associated with the prevalence of sarcopenia risk. Functional limitations, including difficulty performing household activities (OR\u2009=\u20091.96, 95% CI 1.42\u20132.69) and physical inactivity (OR\u2009=\u20091.72, 95% CI 1.40\u20132.11), were also associated with sarcopenia risk. A dose\u2013response relationship was observed with medication use, with progressively higher odds of sarcopenia risk among those taking\u2009&gt;\u20098 medications per day (OR\u2009=\u20092.75, 95% CI 1.52\u20134.98).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings highlight the high prevalence of sarcopenia risk among older adults in Israel and emphasize the importance of early screening to identify at-risk individuals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s41999-025-01297-7","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:43:35Z","timestamp":1757925815000},"page":"43-52","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the risk of sarcopenia among community-dwelling older adults in Israel: a national cross-sectional survey"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0290-3081","authenticated-orcid":false,"given":"Miri","family":"Lutski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7727-7911","authenticated-orcid":false,"given":"Ziv","family":"Karni-Efrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0086-4891","authenticated-orcid":false,"given":"Inbar","family":"Zucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3266-6491","authenticated-orcid":false,"given":"Dvora","family":"Frankenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"issue":"1","key":"1297_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afy169","journal-title":"Age Ageing"},{"issue":"5 Suppl","key":"1297_CR2","doi-asserted-by":"publisher","first-page":"990S","DOI":"10.1093\/jn\/127.5.990S","volume":"127","author":"IH Rosenberg","year":"1997","unstructured":"Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127(5 Suppl):990S-S991. https:\/\/doi.org\/10.1093\/jn\/127.5.990S","journal-title":"J Nutr"},{"key":"1297_CR3","unstructured":"Central Bureau of Statistics, Israel population estimates and projections 2023. Available from: https:\/\/www.cbs.gov.il\/en\/subjects\/Pages\/Population.aspx. Accessed 29 Jul 2025"},{"issue":"1","key":"1297_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jcsm.12783","volume":"13","author":"F Petermann-Rocha","year":"2022","unstructured":"Petermann-Rocha F, Balntzi V, Gray SR, Lara J, Ho FK, Pell JP et al (2022) Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 13(1):86\u201399. https:\/\/doi.org\/10.1002\/jcsm.12783","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"1297_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41572-024-00575-7","volume":"10","author":"AA Sayer","year":"2024","unstructured":"Sayer AA, Cooper R, Arai H, Cawthon PM, Ntsama Essomba MJ, Fielding RA et al (2024) Sarcopenia. Nat Rev Dis Primers 10(1):85. https:\/\/doi.org\/10.1038\/s41572-024-00575-7","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"1297_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"LK Chen","year":"2020","unstructured":"Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K et al (2020) Asian Working Group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 21(3):300-307.e2. https:\/\/doi.org\/10.1016\/j.jamda.2019.12.012","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"1297_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40520-024-02881-w","volume":"37","author":"C Beaudart","year":"2025","unstructured":"Beaudart C, Alcazar J, Aprahamian I, Batsis JA, Yamada Y, Prado CM et al (2025) Health outcomes of sarcopenia: a consensus report by the outcome working group of the Global Leadership Initiative in Sarcopenia (GLIS). Aging Clin Exp Res 37(1):1. https:\/\/doi.org\/10.1007\/s40520-024-02881-w","journal-title":"Aging Clin Exp Res"},{"issue":"3","key":"1297_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afae052","volume":"53","author":"B Kirk","year":"2024","unstructured":"Kirk B, Cawthon PM, Arai H, \u00c1vila-Funes JA, Barazzoni R, Bhasin S et al (2024) The conceptual definition of sarcopenia: Delphi consensus from the Global Leadership Initiative in Sarcopenia (GLIS). Age Ageing 53(3):afae052. https:\/\/doi.org\/10.1093\/ageing\/afae052","journal-title":"Age Ageing"},{"issue":"6","key":"1297_CR9","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s41999-022-00706-5","volume":"13","author":"PM Cawthon","year":"2022","unstructured":"Cawthon PM, Visser M, Arai H, \u00c1vila-Funes JA, Barazzoni R, Bhasin S et al (2022) Defining terms commonly used in sarcopenia research: a glossary proposed by the Global Leadership in Sarcopenia (GLIS) Steering Committee. Eur Geriatr Med 13(6):1239\u20131244. https:\/\/doi.org\/10.1007\/s41999-022-00706-5","journal-title":"Eur Geriatr Med"},{"issue":"1","key":"1297_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4235\/agmr.23.0178","volume":"28","author":"S Chua","year":"2024","unstructured":"Chua S, Chia JQ, Lim JP, Chew J, Lim WS (2024) Case-finding for sarcopenia in community-dwelling older adults: comparison of mini sarcopenia risk assessment with SARC-F and SARC-CalF. Ann Geriatr Med Res 28(1):57\u201364. https:\/\/doi.org\/10.4235\/agmr.23.0178","journal-title":"Ann Geriatr Med Res"},{"issue":"6","key":"1297_CR11","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s12603-017-0921-4","volume":"21","author":"AP Rossi","year":"2017","unstructured":"Rossi AP, Micciolo R, Rubele S, Fantin F, Caliari C, Zoico E et al (2017) Assessing the risk of sarcopenia in the elderly: the Mini Sarcopenia Risk Assessment (MSRA) questionnaire. J Nutr Health Aging 21(6):743\u2013749. https:\/\/doi.org\/10.1007\/s12603-017-0921-4","journal-title":"J Nutr Health Aging"},{"key":"1297_CR12","doi-asserted-by":"publisher","first-page":"E170","DOI":"10.5888\/pcd17.200220","volume":"17","author":"M Lutski","year":"2020","unstructured":"Lutski M, Weinstein G, Tanne D, Goldbourt U (2020) Overweight, obesity, and late-life sarcopenia among men with cardiovascular disease, Israel. Prev Chronic Dis 17:E170. https:\/\/doi.org\/10.5888\/pcd17.200220","journal-title":"Prev Chronic Dis"},{"issue":"5","key":"1297_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1159\/000537752","volume":"70","author":"F Formiga","year":"2024","unstructured":"Formiga F, Moreno-G\u00f3nzalez R, Corsonello A, Mattace-Raso F, Carlsson AC, \u00c4rnl\u00f6v J et al (2024) Prevalence of sarcopenia in chronic heart failure and modulating role of chronic kidney disease. Gerontology 70(5):507\u2013516. https:\/\/doi.org\/10.1159\/000537752","journal-title":"Gerontology"},{"issue":"8","key":"1297_CR14","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.jgo.2022.08.008","volume":"13","author":"SS Shachar","year":"2022","unstructured":"Shachar SS, Bar-Sela G, Peer A, Moskovitz MT, Bareket-Samish A, Epstein J et al (2022) The association between geriatric assessment, muscle measures, and treatment-related toxicity in older adults with cancer: an Israeli prospective study. J Geriatr Oncol 13(8):1203\u20131207. https:\/\/doi.org\/10.1016\/j.jgo.2022.08.008","journal-title":"J Geriatr Oncol"},{"issue":"1","key":"1297_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13584-021-00459-5","volume":"10","author":"D Frankenthal","year":"2021","unstructured":"Frankenthal D, Saban M, Karolinsky D, Lutski M, Sternberg S, Rasooly I et al (2021) Falls and fear of falling among Israeli community-dwelling older people: a cross-sectional national survey. Isr J Health Policy Res 10(1):31. https:\/\/doi.org\/10.1186\/s13584-021-00459-5","journal-title":"Isr J Health Policy Res"},{"issue":"4","key":"1297_CR16","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3390\/nu13041061","volume":"13","author":"R Krzymi\u0144ska-Siemaszko","year":"2021","unstructured":"Krzymi\u0144ska-Siemaszko R, Deskur-\u015bmielecka E, Styszy\u0144ski A, Wieczorowska-Tobis K (2021) Polish translation and validation of the mini sarcopenia risk assessment (MSRA) questionnaire to assess nutritional and non-nutritional risk factors of sarcopenia in older adults. Nutrients 13(4):1061. https:\/\/doi.org\/10.3390\/nu13041061","journal-title":"Nutrients"},{"key":"1297_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/CLEP.S148638","volume":"10","author":"M Locquet","year":"2017","unstructured":"Locquet M, Beaudart C, Reginster JY, Petermans J, Bruy\u00e8re O (2017) Comparison of the performance of five screening methods for sarcopenia. Clin Epidemiol 10:71\u201382. https:\/\/doi.org\/10.2147\/CLEP.S148638","journal-title":"Clin Epidemiol"},{"issue":"4","key":"1297_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.afos.2020.11.002","volume":"6","author":"P Akarapornkrailert","year":"2020","unstructured":"Akarapornkrailert P, Muangpaisan W, Boonpeng A, Daengdee D (2020) Validation of the Thai version of SARC-F, MSRA-7, and MSRA-5 questionnaires compared to AWGS 2019 and sarcopenia risks in older patients at a medical outpatient clinic. Osteoporos Sarcopenia 6(4):205\u2013211. https:\/\/doi.org\/10.1016\/j.afos.2020.11.002","journal-title":"Osteoporos Sarcopenia"},{"issue":"1","key":"1297_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnha.2023.100007","volume":"28","author":"H Zhou","year":"2024","unstructured":"Zhou H, Ding X, Luo M (2024) The association between sarcopenia and functional disability in older adults. J Nutr Health Aging 28(1):100007. https:\/\/doi.org\/10.1016\/j.jnha.2023.100007","journal-title":"J Nutr Health Aging"},{"issue":"4","key":"1297_CR20","doi-asserted-by":"publisher","first-page":"398","DOI":"10.14283\/jfa.2022.34","volume":"11","author":"L Swan","year":"2022","unstructured":"Swan L, Warters A, O\u2019Sullivan M (2022) Socioeconomic disadvantage is associated with probable sarcopenia in community-dwelling older adults: findings from the english longitudinal study of ageing. J Frailty Aging 11(4):398\u2013406. https:\/\/doi.org\/10.14283\/jfa.2022.34","journal-title":"J Frailty Aging"},{"issue":"5","key":"1297_CR21","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/jn\/nxab012","volume":"151","author":"R Doyev","year":"2021","unstructured":"Doyev R, Axelrod R, Keinan-Boker L, Shimony T, Goldsmith R, Nitsan L et al (2021) Energy intake is highly associated with handgrip strength in community-dwelling elderly adults. J Nutr 151(5):1249\u20131255. https:\/\/doi.org\/10.1093\/jn\/nxab012","journal-title":"J Nutr"},{"issue":"1","key":"1297_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13584-018-0214-7","volume":"7","author":"A Buch","year":"2018","unstructured":"Buch A, Keinan-Boker L, Berner Y, Carmeli E, Goldsmith R, Stern N (2018) Estimated frailty prevalence among Israeli elderly\u2014results from a cross sectional national survey. Isr J Health Policy Res 7(1):18. https:\/\/doi.org\/10.1186\/s13584-018-0214-7","journal-title":"Isr J Health Policy Res"},{"issue":"4","key":"1297_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.21767\/2049-5471.1000173","volume":"15","author":"K Du","year":"2018","unstructured":"Du K, Goates S, Arensberg MB, Pereira S, Gaillard T (2018) Prevalence of sarcopenia and sarcopenic obesity vary with race\/ethnicity and advancing age. Divers Equal Health Care 15(4):175\u2013183","journal-title":"Divers Equal Health Care"},{"issue":"6","key":"1297_CR24","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s12603-020-1376-8","volume":"24","author":"X Liu","year":"2020","unstructured":"Liu X, Hao Q, Hou L, Xia X, Zhao W, Zhang Y et al (2020) Ethnic groups differences in the prevalence of sarcopenia using the AWGS criteria. J Nutr Health Aging 24(6):665\u2013671. https:\/\/doi.org\/10.1007\/s12603-020-1376-8","journal-title":"J Nutr Health Aging"},{"issue":"3","key":"1297_CR25","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/13557858.2020.1814999","volume":"27","author":"BG Dorhout","year":"2022","unstructured":"Dorhout BG, Overdevest E, Tieland M, Nicolaou M, Weijs PJM, Snijder MB et al (2022) Sarcopenia and its relation to protein intake across older ethnic populations in the Netherlands: the HELIUS study. Ethn Health 27(3):705\u2013720. https:\/\/doi.org\/10.1080\/13557858.2020.1814999","journal-title":"Ethn Health"},{"issue":"10088","key":"1297_CR26","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1016\/S0140-6736(17)30574-3","volume":"389","author":"K Muhsen","year":"2017","unstructured":"Muhsen K, Green MS, Soskolne V, Neumark Y (2017) Inequalities in non-communicable diseases between the major population groups in Israel: achievements and challenges. Lancet 389(10088):2531\u20132541. https:\/\/doi.org\/10.1016\/S0140-6736(17)30574-3","journal-title":"Lancet"},{"issue":"1","key":"1297_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10823-016-9306-4","volume":"32","author":"RNR Khalaila","year":"2017","unstructured":"Khalaila RNR (2017) Socioeconomic status, health behaviors, obesity and self-rated health among older Arabs in Israel. J Cross Cult Gerontol 32(1):115\u2013130. https:\/\/doi.org\/10.1007\/s10823-016-9306-4","journal-title":"J Cross Cult Gerontol"},{"issue":"3","key":"1297_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00038-017-1065-3","volume":"63","author":"N Daoud","year":"2018","unstructured":"Daoud N, Soskolne V, Mindell JS, Roth MA, Manor O (2018) Ethnic inequalities in health between Arabs and Jews in Israel: the relative contribution of individual-level factors and the living environment. Int J Public Health 63(3):313\u2013323. https:\/\/doi.org\/10.1007\/s00038-017-1065-3","journal-title":"Int J Public Health"},{"issue":"12","key":"1297_CR29","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.3390\/nu13124291","volume":"13","author":"Q Gao","year":"2021","unstructured":"Gao Q, Hu K, Yan C, Zhao B, Mei F, Chen F et al (2021) Associated factors of sarcopenia in community-dwelling older adults: a systematic review and meta-analysis. Nutrients 13(12):4291. https:\/\/doi.org\/10.3390\/nu13124291","journal-title":"Nutrients"},{"issue":"2","key":"1297_CR30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/crt2.32","volume":"6","author":"JA Pasco","year":"2021","unstructured":"Pasco JA, Sui SX, West EC, Holloway-Kew KL, Hyde NK, Stuart AL et al (2021) Operational definitions of sarcopenia should consider depressive symptoms. JCSM Clin Rep 6(2):62\u201368. https:\/\/doi.org\/10.1002\/crt2.32","journal-title":"JCSM Clin Rep"},{"issue":"5","key":"1297_CR31","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11914-015-0279-7","volume":"13","author":"JA Pasco","year":"2015","unstructured":"Pasco JA, Williams LJ, Jacka FN, Stupka N, Brennan-Olsen SL, Holloway KL et al (2015) Sarcopenia and the common mental disorders: a potential regulatory role of skeletal muscle on brain function? Curr Osteoporos Rep 13(5):351\u2013357. https:\/\/doi.org\/10.1007\/s11914-015-0279-7","journal-title":"Curr Osteoporos Rep"},{"issue":"4","key":"1297_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41584-023-00921-9","volume":"19","author":"JL Bennett","year":"2023","unstructured":"Bennett JL, Pratt AG, Dodds R, Sayer AA, Isaacs JD (2023) Rheumatoid sarcopenia: loss of skeletal muscle strength and mass in rheumatoid arthritis. Nat Rev Rheumatol 19(4):239\u2013251. https:\/\/doi.org\/10.1038\/s41584-023-00921-9","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"1297_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/gerona\/glx074","volume":"73","author":"M K\u00f6nig","year":"2017","unstructured":"K\u00f6nig M, Spira D, Demuth I, Steinhagen-Thiessen E, Norman K (2017) Polypharmacy as a risk factor for clinically relevant sarcopenia: results from the Berlin Aging Study II. J Gerontol A Biol Sci Med Sci 73(1):117\u2013122. https:\/\/doi.org\/10.1093\/gerona\/glx074","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"Suppl 1","key":"1297_CR34","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/geroni\/igy031.3681","volume":"2","author":"T Tanaka","year":"2018","unstructured":"Tanaka T, Akishita M, Unyaporn S, Iijima K, Sheikh S, Norse A et al (2018) Polypharmacy as a predictor of sarcopenia, disability, and mortality among community-dwelling older adults. Innov Aging 2(Suppl 1):988. https:\/\/doi.org\/10.1093\/geroni\/igy031.3681","journal-title":"Innov Aging"},{"issue":"1","key":"1297_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12877-023-04135-0","volume":"23","author":"T Tanaka","year":"2023","unstructured":"Tanaka T, Akishita M, Kojima T, Son BK, Iijima K (2023) Polypharmacy with potentially inappropriate medications as a risk factor of new onset sarcopenia among community-dwelling Japanese older adults: a 9-year Kashiwa cohort study. BMC Geriatr 23(1):419. https:\/\/doi.org\/10.1186\/s12877-023-04135-0","journal-title":"BMC Geriatr"},{"issue":"1","key":"1297_CR36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/jcsm.12048","volume":"7","author":"TK Malmstrom","year":"2016","unstructured":"Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE (2016) SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 7(1):28\u201336. https:\/\/doi.org\/10.1002\/jcsm.12048","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"1297_CR37","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1007\/s11357-023-00847-x","volume":"46","author":"X Zhao","year":"2024","unstructured":"Zhao X, Zhang H, Yu J, Zhou Z, Wang J (2024) Physical activity intensity, frequency, duration, volume and the risk of possible sarcopenia in middle-aged and older adults. Geroscience 46(4):3743\u20133757. https:\/\/doi.org\/10.1007\/s11357-023-00847-x","journal-title":"Geroscience"},{"issue":"1","key":"1297_CR38","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12877-024-05447-9","volume":"25","author":"K Silay","year":"2025","unstructured":"Silay K, Selvi OH (2025) Sarcopenic obesity is linked to worse clinical outcomes than sarcopenia or obesity alone in hospitalized older adults. BMC Geriatr 25(1):443. https:\/\/doi.org\/10.1186\/s12877-024-05447-9","journal-title":"BMC Geriatr"},{"issue":"4","key":"1297_CR39","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.clnu.2021.11.014","volume":"41","author":"LM Donini","year":"2022","unstructured":"Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA et al (2022) Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Clin Nutr 41(4):990\u20131000. https:\/\/doi.org\/10.1016\/j.clnu.2021.11.014","journal-title":"Clin Nutr"},{"issue":"5","key":"1297_CR40","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.numecd.2007.10.002","volume":"18","author":"M Zamboni","year":"2008","unstructured":"Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V (2008) Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis 18(5):388\u2013395. https:\/\/doi.org\/10.1016\/j.numecd.2007.10.002","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1297_CR41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","volume":"29","author":"MF Gregor","year":"2011","unstructured":"Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29:415\u2013445. https:\/\/doi.org\/10.1146\/annurev-immunol-031210-101322","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"1297_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/nu11081713","volume":"11","author":"CD Liao","year":"2019","unstructured":"Liao CD, Chen HC, Huang SW, Liou TH (2019) The role of muscle mass gain following protein supplementation plus exercise therapy in older adults with sarcopenia and frailty risks: a systematic review and meta-regression analysis of randomized trials. Nutrients 11(8):1713. https:\/\/doi.org\/10.3390\/nu11081713","journal-title":"Nutrients"},{"key":"1297_CR43","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2024030","volume":"46","author":"P Whaikid","year":"2024","unstructured":"Whaikid P, Piaseu N (2024) The effectiveness of protein supplementation combined with resistance exercise programs among community-dwelling older adults with sarcopenia: a systematic review and meta-analysis. Epidemiol Health 46:e2024030. https:\/\/doi.org\/10.4178\/epih.e2024030","journal-title":"Epidemiol Health"},{"key":"1297_CR44","doi-asserted-by":"publisher","first-page":"1380263","DOI":"10.3389\/fnut.2024.1380263","volume":"11","author":"A Giacosa","year":"2024","unstructured":"Giacosa A, Barrile GC, Mansueto F, Rondanelli M (2024) The nutritional support to prevent sarcopenia in the elderly. Front Nutr 11:1380263. https:\/\/doi.org\/10.3389\/fnut.2024.1380263","journal-title":"Front Nutr"},{"key":"1297_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.876078","volume":"13","author":"MH Baig","year":"2022","unstructured":"Baig MH, Ahmad K, Moon JS, Park SY, Ho Lim J, Chun HJ et al (2022) Myostatin and its regulation: a comprehensive review of myostatin inhibiting strategies. Front Physiol 13:876078. https:\/\/doi.org\/10.3389\/fphys.2022.876078","journal-title":"Front Physiol"},{"issue":"12","key":"1297_CR46","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/S2213-8587(15)00298-3","volume":"3","author":"C Becker","year":"2015","unstructured":"Becker C, Lord SR, Studenski SA, Warden SJ, Fielding RA, Recknor CP et al (2015) Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial. Lancet Diabetes Endocrinol 3(12):948\u2013957. https:\/\/doi.org\/10.1016\/S2213-8587(15)00298-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"1297_CR47","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s11010-024-05102-z","volume":"480","author":"B Wetzlich","year":"2025","unstructured":"Wetzlich B, Nyakundi BB, Yang J (2025) Therapeutic applications and challenges in myostatin inhibition for enhanced skeletal muscle mass and functions. Mol Cell Biochem 480(3):1535\u20131553. https:\/\/doi.org\/10.1007\/s11010-024-05102-z","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"1297_CR48","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S1054-139X(03)00052-1","volume":"33","author":"ND Brener","year":"2003","unstructured":"Brener ND, Billy JOG, Grady WR (2003) Assessment of factors affecting the validity of self-reported health-risk behavior among adolescents: evidence from the scientific literature. J Adolesc Health 33(6):436\u2013457. https:\/\/doi.org\/10.1016\/S1054-139X(03)00052-1","journal-title":"J Adolesc Health"},{"issue":"8","key":"1297_CR49","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1097\/MLR.0000000000000753","volume":"55","author":"P St Clair","year":"2017","unstructured":"St Clair P, Gaudette \u00c9, Zhao H, Tysinger B, Seyedin R, Goldman DP (2017) Using self-reports or claims to assess disease prevalence. Med Care 55(8):782\u2013788. https:\/\/doi.org\/10.1097\/MLR.0000000000000753","journal-title":"Med Care"}],"container-title":["European Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-025-01297-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41999-025-01297-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-025-01297-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:30:52Z","timestamp":1772130652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41999-025-01297-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["1297"],"URL":"https:\/\/doi.org\/10.1007\/s41999-025-01297-7","relation":{},"ISSN":["1878-7657"],"issn-type":[{"value":"1878-7657","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest with respect to the research, authorship, or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"According to Israeli legislation, telephone health surveys are conducted under the regulatory authority of the Israel Center for Disease Control (Ministry of Health) and do not require approval from an ethics committee. Verbal informed consent was obtained from all participants following a brief explanation of the survey\u2019s objectives and significance.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The Israel Center for Disease Control is the research unit of the Israeli Ministry of Health, which is responsible for collecting and publishing data on the health of the population.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}